The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing therapeutics for neurodegenerative disease

Total Raised

$29 M

Rounds

1

Links

Verticals

Biotechnology
Health Care

Investment History

  1. Series A

    Sep 2020

    $29M

Team

Isaac Veinbergs

Founder and CEO

Shawn A. Scranton

President and Chief Executive Officer

Philip Lambert

Chief Scientific Officer

Stefan Lohmer

Board Member